Kewaunee Scientific Q2 FY2026: sales +46.8% to $70.1M, diluted EPS $0.82 vs $1.01

KEWAUNEE SCIENTIFIC CORP /DE/

2026-Q2 EPS reported $1.86 revenue$141,200,000

Sales up 46.8% to $70.1M; net earnings $2.45M (-18.7%); diluted EPS $0.82 (vs $1.01).
Domestic sales $55.2M (+51.7%) driven by Nu Aire; segment earnings $3.6M (down from $4.5M).
International sales $14.9M (+31.0%) on large project deliveries; segment earnings $0.64M vs $0.36M.
Backlog $192.9M (near record); management reports strong quoting but expects delivery volatility.
Debt-to-equity improved to 0.88x; early repayment of Seller Notes strengthens balance sheet.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.